Medicinova Inc. Stock
Medicinova Inc. Stock
With 6 Buy predictions and not the single Sell prediction the community is currently very high on Medicinova Inc..
Based on the current price of 3.22 € the target price of 7 € shows a potential of 117.53% for Medicinova Inc. which would more than double the current price.
Pros and Cons of Medicinova Inc. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medicinova Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medicinova Inc. | - | - | - | - | - | - | - |
| Heron Therapeutics Inc. | 6.690% | -9.705% | -35.516% | -75.562% | -75.781% | -82.250% | -96.892% |
| Evolus Inc | -1.960% | -1.431% | 38.465% | 13.884% | 26.422% | -21.257% | -22.584% |
| Rhythm Pharmaceuticals | -1.510% | -2.970% | 5.376% | 18.788% | 4.813% | 315.254% | 870.297% |
Comments
MediciNova (MNOV) had its "buy" rating reaffirmed by Maxim Group. They now have a $6.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat
MediciNova (MNOV) is now covered by HC Wainwright. They set a "buy" rating and a $10.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat
MediciNova (NASDAQ:MNOV) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $9.00 price target on the stock.
Show more
Ratings data for MNOV provided by MarketBeat